Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
89%
Ribavirin
86%
Antibody
53%
Triazole
51%
Nanomaterial
41%
Immunoglobulin A
41%
Nucleic Acid
41%
Adenosine Kinase
41%
Vaccine
41%
Dengue Virus
41%
Flavivirus
41%
Drug
35%
Animal
35%
Antivirus Agent
34%
Dihydrofolate Reductase
33%
Hemorrhagic Fever with Renal Syndrome
31%
Clinical Study
31%
Hantaan Virus
31%
HIV
28%
Triazole Derivative
27%
Diseases
27%
Protein
26%
Nanoparticle
24%
Virus
24%
Biodistribution
22%
Hantavirus
20%
Guanosine Triphosphate
20%
Antigen
16%
Peptide
16%
Mouse
15%
Fluorescein Isothiocyanate
15%
Initiation Factor 4E
13%
Antisense Oligonucleotide
13%
Human Immunodeficiency Virus Vaccine
13%
Peptides and Proteins
13%
Trimethoprim
12%
Copper 64
12%
Single Chain Fragment Variable Antibody
11%
EC50
10%
Lead Compounds
10%
Prognosis
10%
Survival
10%
Lead
10%
Crimean-Congo Hemorrhagic Fever Virus
10%
Andes Virus
10%
Rift Valley Fever Virus
10%
Antiviral Therapy
10%
Nucleoside Analog
10%
Guanosine
10%
Pyrrole
10%
Biochemistry, Genetics and Molecular Biology
Self Concept
100%
Protein
86%
Oligonucleotide
55%
Methotrexate
54%
Dihydrofolate Reductase
45%
Nucleoside
41%
Ribavirin
41%
Small Molecule
33%
Nucleotide
33%
Hantaan Virus
31%
Peptide
30%
Antibody
30%
Electric Potential
28%
Virion
27%
Human Immunodeficiency Virus
20%
Hantavirus
20%
Antiviral Activity
20%
Fusion Protein
20%
Molecule
19%
Histidine
16%
Binding Protein
16%
Mouse
15%
Positron Emission Tomography
13%
Membrane Transport Proteins
13%
Single-Chain Variable Fragment
13%
Virus
13%
Conjugate
13%
Microscopy
13%
Clinical Trial
13%
Conjugation
13%
Antisense
13%
Translation Initiation
13%
Synthesis
13%
Initiation Factor
13%
Eukaryotic Translation
13%
Contrast
13%
Epidermal Growth Factor Receptor
11%
Crimean-Congo Hemorrhagic Fever Virus
10%
Andes Virus
10%
Virus Genome
10%
Rift Valley Fever Virus
10%
Mutation Rate
10%
EC50
10%
Survival
10%
Riboside
10%
Length
9%
Human
8%
Position
8%
Mutant
8%
Wild Type
8%
Medicine and Dentistry
Vaccine
41%
Lymph Node
41%
Ribavirin
41%
Hantaan Virus
31%
Triazole
31%
Hemorrhagic Fever with Renal Syndrome
31%
Tissues
24%
Positron Emission Tomography
24%
Nanoparticle
24%
Biodistribution
22%
Therapeutic Procedure
20%
Diseases
20%
Antiviral Activity
20%
Protein
19%
In Vitro
18%
Antigen
16%
Immunization
16%
Computed Tomography
16%
Methotrexate
13%
Cells
13%
Dihydrofolate Reductase
11%
Andes Virus
10%
Crimean-Congo Hemorrhagic Fever Virus
10%
Patient
10%
Chemotherapeutic Agent
10%
Rift Valley Fever Virus
10%
Mechanism of Action
10%
Lead
10%
Mutation Rate
10%
Survival
10%
Antivirus Agent
10%
Drug
10%
Virus Genome
10%
Guanosine Triphosphate
10%
Enalapril Maleate
8%
Lipid
8%
Injection Site
8%
Follicle
8%
Thigh
8%
Human Immunodeficiency Virus
8%
Follicular Dendritic Cells
8%
B Cell
8%
Comprehension
8%
Albumin
8%
Genitourinary System
8%
Mucosal Immunity
8%
Whole Animal
8%
Subunit Vaccine
8%
Lymph Duct
8%
Copper 64
5%
